Emcure Pharmaceuticals Ratios

Emcure Pharmaceuticals Ltd Ratios

The Emcure Pharmaceuticals Ltd Ratios page provides a complete fundamental analysis of Emcure Pharmaceuticals Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Emcure Pharmaceuticals Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Emcure Pharmaceuticals Ltd (NSE: EMCURE, BSE: 544210) is currently trading at ₹1499.40, with a market capitalization of ₹280.11B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Emcure Pharmaceuticals Ltd remains a key stock for fundamental analysis using Emcure Pharmaceuticals Ltd Ratios.

Emcure Pharmaceuticals Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Emcure Pharmaceuticals Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Emcure Pharmaceuticals Ltd Ratios.

Historically, the Emcure Pharmaceuticals Ltd P/E ratio has shown strong fluctuations:

The decline in Emcure Pharmaceuticals Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Emcure Pharmaceuticals Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Emcure Pharmaceuticals Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Emcure Pharmaceuticals Ltd P/S ratio currently stands at 0, an important part of Emcure Pharmaceuticals Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Emcure Pharmaceuticals Ltd P/S ratio indicates cautious market sentiment.

Emcure Pharmaceuticals Ltd Price to Cash Flow Ratio (P/CF)

The Emcure Pharmaceuticals Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Emcure Pharmaceuticals Ltd Price to Cash Flow Ratio:

The declining Emcure Pharmaceuticals Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Emcure Pharmaceuticals Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Emcure Pharmaceuticals Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Emcure Pharmaceuticals Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Emcure Pharmaceuticals Ltd EV/EBITDA ratio is currently 0, a key metric in Emcure Pharmaceuticals Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Emcure Pharmaceuticals Ltd EV/EBITDA indicates balanced valuation.

Emcure Pharmaceuticals Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Emcure Pharmaceuticals Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Emcure Pharmaceuticals Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Emcure Pharmaceuticals Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Emcure Pharmaceuticals Ltd Ratios Analysis Summary

The Emcure Pharmaceuticals Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Emcure Pharmaceuticals Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Emcure Pharmaceuticals Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.